FEI Company Announces Dates for Investor Conference Participation
Jan 06, 2016 21:05 pm UTC| Business
HILLSBORO, Ore., Jan. 06, 2016 (GLOBE NEWSWIRE) -- FEI Company (NASDAQ:FEIC) today announced that company management is scheduled to participate at two upcoming investor conferences. Don Kania, President and CEO, will...
The Fresh Market Inc. Names Pamela Kohn Chief Merchandising Officer
Jan 06, 2016 21:05 pm UTC| Business
GREENSBORO, N.C., Jan. 06, 2016 (GLOBE NEWSWIRE) -- The Fresh Market, Inc. (NASDAQ:TFM), a growing specialty grocery retailer, announced today the appointment of Pamela Kohn as Executive Vice President and Chief...
Five Prime Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference
Jan 06, 2016 21:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein...
Novavax to Present at the 34th Annual J.P. Morgan Healthcare Conference
Jan 06, 2016 21:02 pm UTC| Business
GAITHERSBURG, Md., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and...
Caladrius Tightens Strategic Focus and Provides 2016 Revenue Guidance
Jan 06, 2016 21:01 pm UTC| Business
Emphasizes PCT subsidiary’s leadership position in the emerging cell therapy market with expectations for 30% revenue growth in 2016 Focuses clinical development on innovative platform of immune modulation with T...
Spark Therapeutics Announces Addition of Lota Zoth to Its Board of Directors
Jan 06, 2016 21:01 pm UTC| Business
PHILADELPHIA, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics, Inc. (NASDAQ:ONCE) announced today that Lota Zoth, CPA, a long-time financial executive at multiple publicly listed companies, has been named to the...
Jan 06, 2016 21:01 pm UTC| Business
DEVON, Pa., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments,...